Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
The DOI matches its Crossref record; 24 of the 26 references it cites were found in a registry or an index.
Abstract
Background CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy) is commonly overlooked or misdiagnosed owing to its recent identification and its variable mode of presentation. The defective gene in CADASIL is Notch3, which encodes a large transmembrane receptor. To set up a diagnostic test and to delineate the Notch3 domains involved in CADASIL., we undertook mutations analysis in this gene in a group of CADASIL patients.Methods 50 unrelated patients with CADASIL and 100 healthy controls were screened for mutations along the entire Notch3 sequence, by means of single-strand conformation polymorphism, heteroduplex, and sequence analysis.Findings Strongly stereotyped mis-sense mutations, located within the epidermal-growth-factor-like (EGF-like) repeats, in the extracellular domain of Notch3, were detected in 45 patients. Clustering of mutations within the two exons encoding the first five EGF-like repeats was observed (32 patients). All these mutations lead to loss or gain of a cysteine residue and therefore to an unpaired number of cysteine residues within a given EGF domain. None of these mutations was found in the 100 controls.Interpretation Because of the strong clustering and highly stereotyped nature of the pathogenetic mutations detected in CADASIL patients, and easy and reliable diagnostic test for CADASIL is feasible. The findings suggest that aberrant dimerisation of Notch3, due to abnormal disulphide bridging with another Notch3 molecule or with another protein, may be involved in the pathogenesis of this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nearly all cases of CADASIL are caused by missense mutations of the Notch3 gene that either create or eliminate cysteine residues.165”
Citations
Cites
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
Self-citationArtavanis-Tsakonas, S., Matsuno, K., & Fortini, M. E. (1995) · Science · doi:10.1126/science.7716513 · Cited by 1,303
Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., et al. (1995) · Science · doi:10.1126/science.7824936 · Cited by 841
Rebay, I., Fleming, R. J., Fehon, R. G., Cherbas, L., Cherbas, P., & Artavanis-Tsakonas, S. (1991) · Cell · doi:10.1016/0092-8674(91)90064-6 · Cited by 772
Tournier-Lasserve, E., Joutel, A., Melki, J., Weissenbach, J., Lathrop, G. M., Chabriat, H., Mas, J.-L., Cabanis, E.-A., Baudrimont, M., Maciazek, J., et al. (1993) · Nature Genetics · doi:10.1038/ng0393-256 · Cited by 682
Self-citationClinical spectrum of CADASIL: a study of 7 families
Chabriat, H., Vahedi, K., Bousser, M. G., Iba-Zizen, M. T., Joutel, A., Nibbio, A., Nagy, T. G., Tournier Lasserve, E., Krebs, M. O., Julien, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91557-5 · Cited by 669
Self-citationRebay, I., Fehon, R. G., & Artavanis-Tsakonas, S. (1993) · Cell · doi:10.1016/0092-8674(93)90423-n · Cited by 409
Epidermal growth factor-like modules
Campbell, I. D., & Bork, P. (1993) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(05)80111-3 · Cited by 351
Ruchoux, M. M., Guerouaou, D., Vandenhaute, B., Pruvo, J.-P., Vermersch, P., & Leys, D. (1995) · Acta Neuropathologica · doi:10.1007/bf00571504 · Cited by 329
Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study.
Baudrimont, M., Dubas, F., Joutel, A., Tournier-Lasserve, E., & Bousser, M. G. (1993) · Stroke · doi:10.1161/01.str.24.1.122 · Cited by 321
Self-citation
Research works printed but not linked: 1
- Davous, 1991, Démence sous corticale familiale avec leucoencéphalopathie artériopathique: observation clinicopathologique., Rev Neurol (Paris), 5, 376
Cited by
Items 301–400 of 735
Yamamoto, S. (2020) · Development Growth & Differentiation · doi:10.1111/dgd.12640 · Cited by 25
“Another interesting but unexplained aspect of CADASIL alleles is that although NOTCH3 has 34 EGFr, most of the variants linked to this disease are found in EGFr-1–5 (corresponding to EGFr-1–6 in Drosophila Notch which has 36 EGFr) (Joutel et al., 1997; Masek & Andersson, 2017).”
BackgroundOverlapping Protein Accumulation Profiles of CADASIL and CAA
Young, K. Z., Xu, G., Keep, S. G., Borjigin, J., & Wang, M. M. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.11.015 · Cited by 25
How understudied populations have contributed to our understanding of Alzheimer’s disease genetics
Dehghani, N., Brás, J., & Guerreiro, R. J. (2021) · Brain · doi:10.1093/brain/awab028 · Cited by 25
Genotype and Phenotype Differences in CADASIL from an Asian Perspective
Kim, Y., Bae, J. S., Lee, J.-Y., Song, H. K., Lee, J.-H., Lee, M., Kim, C., & Lee, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911506 · Cited by 25
Iglesias, S., Chapon, F., & Baron, J. (2000) · Neurology · doi:10.1212/wnl.55.11.1661 · Cited by 25
Investigating diagnostic sequencing techniques for CADASIL diagnosis
Dunn, P. J., Maksemous, N., Smith, R. A., Sutherland, H. G. E., Haupt, L. M., & Griffiths, L. R. (2020) · Human Genomics · doi:10.1186/s40246-019-0255-x · Cited by 25
CNS vasculopathies: Challenging mimickers of primary angiitis of the central nervous system
Cho, T. A., & Jones, A. (2020) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101569 · Cited by 24
Lee, Y., Yang, A., Liu, H.-C., Wong, W.-J., Lu, Y., Chang, M.-H., & Soong, B. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.02.011 · Cited by 24
“Most CADASIL associated NOTCH3 mutations reported so far result in a gain or loss of one cysteine residue within a given EGF-like repeat domain and with a strong cluster in exons 3 and 4 coding for the first five EGF-like repeats [7].”
BackgroundArg133Cys Mutation of Notch3 in Two Unrelated Japanese Families with CADASIL.
Uyama, E., Tokunaga, M., Suenaga, A., Kotorii, S., Kamimura, K., Takahashi, K., Tabira, T., & Uchino, M. (2000) · Internal Medicine · doi:10.2169/internalmedicine.39.732 · Cited by 24
Genetic Animal Models of Cerebral Vasculopathies
Lee, J. H., Bacskai, B. J., & Ayata, C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00002-0 · Cited by 24
“The vast majority of pathogenic CADASILmutations aremissensemutations within the extracellular domain of NOTCH3 receptor that cause either a gain or a loss of cysteine residue resulting in an odd number of cysteins.(170,171) The unpaired cysteine residues lead to conformational changes of NOTCH3 extracellular domain,…”
BackgroundExtracranial arteriovenous malformations: from bedside to bench
Qiao, C., Richter, G. T., Pan, W., Jin, Y., & Lin, X. (2019) · Mutagenesis · doi:10.1093/mutage/gez028 · Cited by 23
NOTCH3 is non-enzymatically fragmented in inherited cerebral small-vessel disease
Young, K. Z., Lee, S. J., Zhang, X., Cartee, N. M. P., Torres, M., Keep, S. G., Gabbireddy, S. R., Fontana, J. L., Qi, L., & Wang, M. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007724 · Cited by 23
“All CADASIL-causing mutations in NOTCH3 thus far have been mapped to the N-terminal extracellular domain, which is composed of a tandem series of 34 epidermal growth factor (EGF)-like domains (9, 11, 16).”
BackgroundUyguner, Z. O., Sıva, A., Kayserili, H., Saip, S., Altıntaş, A., Apak, M. Y., Albayram, S., Işik, N., Akman‐Demir, G., Taşyürekli, M., et al. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.02.021 · Cited by 23
“with CADASIL [8].”
BackgroundDeeble, V. J., ROBERTS, E., JACKSON, A., Lench, N., KARBANI, G., & Woods, C. G. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.219 · Cited by 24
Blood biomarkers in a mouse model of CADASIL
Primo, V. A., Graham, M., Bigger-Allen, A. A., Chick, J. M., Ospina, C., Quiroz, Y. T., Manent, J., Gygi, S. P., Lopera, F. J., D'Amore, P. A., et al. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.008 · Cited by 24
CADASIL management or what to do when there is little one can do
Río-Espínola, A. D., Mendióroz, M., Domingues‐Montanari, S., Pozo‐Rosich, P., Solé, E., Fernández‐Morales, J., Fernández‐Cadenas, I., & Montaner, J. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.2.197 · Cited by 24
Clinical Forms of Vascular Dementia
Román, G. C. (2005) · Humana Press eBooks · doi:10.1385/1-59259-824-2:007 · Cited by 24
“This pattern of clinical onset and progression is the same one observed in patients with CADASIL ( 80-82 ).”
BackgroundResultGuerrot, D., François, A., Boffa, J., Boulos, N., Hanoy, M., Legallicier, B., Triquenot-Bagan, A., Guyant‐Maréchal, L., Laquerrière, A., Fréguin-Bouilland, C., et al. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.04.017 · Cited by 23
Peyruchaud, O., Schmugge, M., Clemetson, K. J., Cazes, E., Combrié, R., Bourre, F., & Nurden, A. T. (1999) · British Journal of Haematology · doi:10.1111/j.1365-2141.1999.01376.x · Cited by 23
“…cysteine residues are well known in inherited disease, as for example in the transmembrane Notch3 protein and responsible for CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy), a condition responsible for stroke and dementia (Joutel et al, 1997).”
BackgroundMembers of the task force on molecular diagnosis of neurologic disorders: T. Gasser, G. M. D. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00228.x · Cited by 23
Valenti, R. (2019) · Premio Tesi dottorato/Premio Tesi di dottorato · doi:10.36253/978-88-6453-779-5 · Cited by 24
Kim, H., Lim, Y., Lee, E., Oh, Y. J., & Kim, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234797 · Cited by 22
Rufa, A., Dotti, M. T., Frezzotti, P., Stefano, N. D., Caporossi, A., & Federico, A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1230 · Cited by 22
Small Vessel Vasculopathies Affecting the Central Nervous System
Bousser, M., & Biousse, V. R. (2004) · Journal of Neuro-Ophthalmology · doi:10.1097/00041327-200403000-00012 · Cited by 22
Self-citationGenetic Mechanisms of Migraine: Insights from Monogenic Migraine Mutations
Gosalia, H., Karsan, N., & Goadsby, P. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612697 · Cited by 21
Impaired vasoreactivity in mildly disabled CADASIL patients
Campolo, J., Maria, R. D., Frontali, M., Taroni, F., Inzitari, D., Federico, A., Romano, S., Puca, E., Mariotti, C., Tomasello, C., et al. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300080 · Cited by 21
Bersano, A., Ranieri, M., Ciammola, A., Cinnante, C. M., Lanfranconi, S., Dotti, M. T., Candelise, L., Baschirotto, C., Ghione, I., Ballabio, E., et al. (2012) · Europe PMC (PubMed Central) · Cited by 21
Transendocytosis is impaired in CADASIL-mutant NOTCH3
Watanabe-Hosomi, A., Watanabe, Y., Tanaka, M., Nakagawa, M., & Mizuno, T. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.020 · Cited by 21
“Since the causative NOTCH3 mutations for CADASIL result in an odd number of cysteine residues in the EGF-like repeats, the formation of abnormal disulfide bridges has been believed to affect ligand binding and signal transduction (Joutel et al., 1997).”
BackgroundFormes pauci symptomatiques de CADASIL après 60 ans
Mourad, A., Levasseur, M., Bousser, M., & Chabriat, H. (2006) · Revue Neurologique · doi:10.1016/s0035-3787(06)75085-8 · Cited by 21
Self-citationCADASIL and genetics of cerebral ischaemia
Kalaria, R. N., Low, W.-C., Oakley, A. E., Slade, J. Y., Ince, P. G., Morris, C. M., & Mizuno, T. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6137-1_5 · Cited by 21
Rafałowska, J., Fidziańska, A., Dziewulska, D., Podlecka‐Piętowska, A., Szpak, G. M., & Kwieciński, H. (2004) · Neuropathology · doi:10.1111/j.1440-1789.2003.00527.x · Cited by 21
Protein O-Fucosyltransferases: Biological Functions and Molecular Mechanisms in Mammals
Hao, H., Eberand, B. M., Larance, M., & Haltiwanger, R. S. (2025) · Molecules · doi:10.3390/molecules30071470 · Cited by 20
Lee, S. J., Zhang, X., Wu, E., Sukpraphrute, R., Sukpraphrute, C., Ye, A., & Wang, M. M. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104838 · Cited by 20
Ishiyama, H., Kim, H., Saitô, S., Takeda, S., Takegami, M., Yamamoto, Y., Abe, S., Nakazawa, S., Tanaka, T., Washida, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26916 · Cited by 20
“14,15 Moreover, the NOTCH3 aggregation property is associated with temporopolar lesions in CADASIL, regardless of cysteine involvement.”
BackgroundCerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Guidetti, D., Casali, B., Mazzei, R., & Dotti, M. T. (2006) · Clinical and Experimental Hypertension · doi:10.1080/10641960600549223 · Cited by 20
“Members of the Notch 3 gene family encode evolutionarily conserved transmembrane receptors and are involved in cell fate specification during embryonic development (8).”
Abe, K., Murakami, T., Matsubara, E., Manabe, Y., NAGANO, I., & Shoji, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04825.x · Cited by 20
Two novel mutations and a previously unreported intronic polymorphism in the NOTCH3 gene
Roy, B., Maksemous, N., Smith, R. A., Menon, S., Davies, G., & Griffiths, L. R. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.02.004 · Cited by 20
“His170Arg (which causes an adenine to guanine nucleotide change at position 587 in exon 4) is an amino acid changing polymorphism[13] which we found in one of our patients who also had two other non amino acid changing polymorphisms, namely Ala202Ala (exon 4) and Thr101Thr (exon 3) in the NOTCH3 gene.”
BackgroundInfluentialUltrastructural picture of blood vessels in muscle and skin biopsy in CADASIL.
Lewandowska, E., Leszczyńska, A. N., Wierzba‐Bobrowicz, T., Skowrońska, M., Mierzewska, H., Pasennik, E., & Członkowska, A. (2006) · PubMed · Cited by 20
Diagnosis, Classification and Natural History of Degenerative Dementias
Feldman, H., & Kertesz, A. (2001) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100001177 · Cited by 20
Silberstein, S. D. (2001) · Elsevier eBooks · doi:10.1016/b978-0-323-03354-1.50060-2 · Cited by 20
Markus, H. S. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.036202 · Cited by 20
“and epilepsy. All mutations reported to date result in the gain or loss of a cysteine residue forming part of paired disulphide bonds in epidermal growth like factor repeats in the extracellular portion of the transmembrane notch 3 protein.”
BackgroundGenotype–phenotype correlations of cysteine replacement in CADASIL
Matsushima, T., Conedera, S., Tanaka, R., Li, Y., Yoshino, H., Funayama, M., Ikeda, A., Hosaka, Y., Okuzumi, A., Shimada, Y., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.10.026 · Cited by 19
The first deep intronic mutation in the NOTCH3 gene in a family with late-onset CADASIL
Bianchi, S., Dotti, M. T., Gallus, G. N., D’Eramo, C., Donato, I. D., Bernardi, L., Maletta, R., Puccio, G., Bruni, A. C., & Federico, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.005 · Cited by 19
“CADASIL is caused by mutations in the NOTCH3 gene, and genetic testing is the gold standard for diagnosis (Joutel et al., 1997).”
BackgroundNOTCH2NLC expanded GGC repeats in patients with cerebral small vessel disease
Wang, Y., Fan, Y., Yu, W.-K., Shen, S., Li, J.-D., Gao, Y., Ji, Y., Li, Y., Yu, L.-L., Zhao, Z., et al. (2022) · Stroke and Vascular Neurology · doi:10.1136/svn-2022-001631 · Cited by 19
Characteristics of CADASIL in Chinese mainland patients
Zhang, J., Tan, Q.-C., Cui, R.-T., Xu, Q., Huang, X., & Yu, S. (2014) · Neurology India · doi:10.4103/0028-3886.136900 · Cited by 19
Pescini, F., Donnini, I., Cesari, F., Nannucci, S., Valenti, R., Rinnoci, V., Poggesi, A., Gori, A. M., Giusti, B., Rogolino, A. A., et al. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.10.027 · Cited by 19
Diagnostic strategies in CADASIL.
Oberstein, S. A. J. L. (2003) · PubMed · Cited by 19
Diagnosing CADASIL using MRI: evidence from families with known mutations of Notch 3 gene
Chawda, S. J., De Lange, R. P. J., Hourihan, M. D., Halpin, S. F. S., & St. Clair, D. (2000) · Neuroradiology · doi:10.1007/s002340050880 · Cited by 18
“All those affected have the disease haplotype and carry a mutation in exon 4 of Notch 3. Mutations were found at cDNA nucleotide positions 475 in family 1 and 583 in family 2; both were described by Joutel et al. [ 23 ].”
BackgroundRagno, M., Pianese, L., Pinelli, M., Silvestri, S., Cacchiò, G., Marzio, F. D., Scarcella, M., Coretti, F., Altamura, F., Monticelli, A., et al. (2011) · Neurogenetics · doi:10.1007/s10048-011-0298-1 · Cited by 18
“NOTCH3 gene pathogenic mutations alter the number of cysteine residues in the extracellular domain of the receptor, leading to its abnormal accumulation in the vascular smooth muscle cells and brain pericytes of patients [9, 11].”
CADASIL: The Most Common Hereditary Subcortical Vascular Dementia
Kalimo, H., Miao, Q., Tikka, S., Mykkänen, K., Junna, M., Roine, S., Viitanen, M. H., Pöyhönen, M., & Baumann, M. (2008) · Future Neurology · doi:10.2217/14796708.3.6.683 · Cited by 18
Jiang, D., Zhuang, J., Peng, W., Lu, Y., Liu, H., Zhao, Q. C., Chi, C., Li, X., Zhu, G., Xu, X., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005537 · Cited by 18
“Notch3 mutations in humans lead to cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy but have no effect on intima formation.(10,13) Notch4 is highly expressed in endothelial cells but not in VSMCs.”
BackgroundOkada, T., Washida, K., Irie, K., Saitô, S., Noguchi, M., Tomita, T., Koga, M., Toyoda, Ḱ., Okazaki, S., Koizumi, T., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00130 · Cited by 19
“CADASIL is themost common hereditary small vessel disease, and the estimated prevalence is 2-5/100,000 individuals in clinical practice (Joutel et al., 1997).”
BackgroundCappelli, A., Ragno, M., Cacchiò, G., Scarcella, M., Staffolani, P., & Pianese, L. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.087 · Cited by 18
Temporal and Embryonic Lineage-Dependent Regulation of Human Vascular SMC Development by NOTCH3
Granata, A., Bernard, W. G., Zhao, N., McCafferty, J., Lilly, B., & Sinha, S. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0520 · Cited by 18
“These findings have potential clinical relevance since mutations in NOTCH3 cause the late-onset genetic vascular condition, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) [34,35].”
Panahi, M., Mesri, N. Y., Samuelsson, E., Coupland, K., Forsell, C., Graff, C., Tikka, S., Winblad, B. G., Viitanen, M. H., Karlström, H., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13534 · Cited by 18
“Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common form of hereditary small vessel disease and is the most common genetic cause of stroke and vascular dementia in adults.(1,2) The clinical presentation of CADASIL is characterized by migraine with aur…”
BackgroundChoudhary, S., McLeod, M. P., Torchia, D., & Romanelli, P. (2013) · Europe PMC (PubMed Central) · Cited by 18
Migraine: an ophthalmologist's perspective
Arunagiri, G., & Santhi, S. (2003) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200312000-00005 · Cited by 18
Multiple sclerosis or “inflammatory CADASIL?”: Case Report and review of the literature
Schiess, N., Huether, K., Szolics, M., Agarwal, G., El-Hattab, A. W., & Sathe, S. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.01.035 · Cited by 17
Oka, F., Lee, J. H., Yuzawa, I., Li, M., von Bornstaedt, D., Eikermann‐Haerter, K., Qin, T., Chung, D. Y., Sadeghian, H., Seidel, J. L., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci149759 · Cited by 17
“The disease is caused by highly stereotyped mutations in the NOTCH3 receptor, which is predominantly expressed in pericytes and smooth muscle cells of small vessels (4-6).”
BackgroundSelf-citationZhang, W., Zhao, X., Qi, X., Kimber, S. J., Hooper, N. M., & Wang, T. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1195470 · Cited by 17
“Patients with CADASIL usually experience recurrent ischemic strokes, migraines with aura, psychiatric disturbances and seizures, and gradually develop to cognitive impairment and vascular dementia (Joutel et al., 1997; Charlton et al., 2006; Chabriat et al., 2009; Adib-Samii et al., 2010).”
BackgroundAhn, Y., An, J.-H., Yang, H.-J., Lee, W.-J., Lee, S., Park, Y., Lee, J. H., Lee, H. J., Lee, S. H., & Kim, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04141-4 · Cited by 17
“Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most prevalent hereditary stroke disorder [1, 2].”
BackgroundStroke-Related Translational Research
Caplan, L. R., Arenillas, J. F., Cramer, S. C., Joutel, A., Lo, E. H., Meschia, J. F., Savitz, S. I., & Tournier‐Lasserve, E. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.99 · Cited by 17
“First, an analysis of very large families has established a perfect segregation of these mutations (commonly called “cysteine mutations”) with the disease phenotype.(16) Second, the occurrence of a de novo noninherited cysteine mutation has been shown in a few patients.”
Self-citationProspects for Diminishing the Impact of Nonamyloid Small-Vessel Diseases of the Brain
Joutel, A. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021712 · Cited by 17
Self-citationMeng, H., Zhang, X., Lee, S. J., & Wang, M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075808 · Cited by 18
“For example, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), the most common inherited cause of vascular dementia [12], is caused by mutations in NOTCH3 [13], a gene preferentially expressed in vascular smooth muscle [14,15].”
BackgroundLatent NOTCH3 epitopes unmasked in CADASIL and regulated by protein redox state
Zhang, X., Lee, S. J., Young, K. Z., Josephson, D. A., Geschwind, M. D., & Wang, M. M. (2014) · Brain Research · doi:10.1016/j.brainres.2014.08.018 · Cited by 17
“The primary sequence of NOTCH3 features a large extracellular domain which is the site of almost all mutations linked to CADASIL (Joutel et al., 1997).”
BackgroundYin, X., Wu, D., Wan, J., Yan, S., Lou, M., Zhao, G., & Zhang, B. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.951929 · Cited by 17
“As most previously reported mutations [1,15,18], all the eight cysteine-altering missense mutations”
BackgroundNeuroimaging of Cerebral Small Vessel Disease
Salamon, N. (2014) · Brain Pathology · doi:10.1111/bpa.12179 · Cited by 17
Gurumukhani, J. K., Ursekar, M. A., & Singhal, B. S. (2004) · PubMed · Cited by 17
WANG, J., BOWMAN, M. C., Hsu, E. K., WERTZ, K., & WONG, L.-J. C. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.215 · Cited by 17
He, D., Chen, D., Li, X., Hu, Z., Yu, Z., Wang, W., & luo, X. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0646-5 · Cited by 16
“24 of 116 patients were genetically confirmed to be diagnosed as CADASIL with NOTCH3 mutation [3].”
BackgroundClinical, familial, and neuroimaging features of CADASIL‐like patients
Nannucci, S., Pescini, F., Bertaccini, B., Bianchi, S., Ciolli, L., Valenti, R., Dotti, M. T., Federico, A., Inzitari, D., & Pantoni, L. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12284 · Cited by 16
“The disease is caused by highly stereotyped mutations within the epidermal growth factor (EGF)-like repeats encoded by NOTCH3 gene, leading to an odd number of cysteine residues [1,11].”
BackgroundGuo, L., Jiao, B., Liao, X., Xiao, X., Zhang, W., Yuan, Z., Liu, X., Zhou, L., Wang, X., Zhu, Y., et al. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13647 · Cited by 16
Nam, T., Kim, J. H., Chang, C.-H., Yoon, W., Jung, Y. S., Kang, S., Shin, B. A., Perng, M., Choi, S., & Kim, M.-K. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.68 · Cited by 16
A Novel Mutation (C67Y) in the NOTCH3 Gene in a Korean CADASIL Patient
Na, D. L., Moon, S.-Y., Kim, H.-Y., Seok, J.-I., Kwon, J.-C., Ki, C., Kim, J., & Suh, Y. (2003) · Journal of Korean Medical Science · doi:10.3346/jkms.2003.18.1.141 · Cited by 16
“Since the defective gene associated with CADASIL was discovered in NOTCH3 in 1996 (1), at least 80 CADASIL patients with NOTCH3 mutations have been reported in different ethnic groups (2-6).”
Piccirillo, G., Magrì, D., Mitra, M., Rufa, A., Zicari, E., Stromillo, M. L., Stefano, N. D., & Dotti, M. T. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02300.x · Cited by 16
“Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited and generalized small- and medium-sized arteriopathy caused by highly stereotyped mutations in the Notch3 gene [1].”
BackgroundNeuromuscular Implications in CADASIL
Finsterer, J. (2007) · Cerebrovascular Diseases · doi:10.1159/000108428 · Cited by 16
“Results Notch3 Gene, Protein Product, and Function The Notch3 gene is located on chromosome 19 and encodes for the large, transmembrane receptor protein Notch3 [ ,”
BackgroundBroadley, S. A. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.1.97 · Cited by 16
No evidence of germline PTEN mutations in familial prostate cancer
Forrest, M. S., EDWARDS, S. M., Hamoudi, R., Dearnaley, D. P., ARDEN-JONES, A., DOWE, A., MURKIN, A., KELLY, J., Teare, M. D., Easton, D. F., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.210 · Cited by 17
Milunsky, A., Konialis, C. P., Shim, S. H., Maher, T. A., Spengos, K., Ito, M., & Pángalos, C. (2005) · Prenatal Diagnosis · doi:10.1002/pd.1302 · Cited by 16
“The R153C mutation in exon 4 has been reported previously (Joutel et al., 1997).”
BackgroundGatti, J. R., Zhang, X., Korcari, E., Lee, S. J., Greenstone, N. E., Dean, J. G., Maripudi, S., & Wang, M. M. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0643-x · Cited by 15
“In 1997, Joutel and colleagues identified stereotyped mutations in NOTCH3 in families with CADASIL [4].”
NOTCH3 gene mutations in subjects clinically suspected of CADASIL
Mosca, L., Marazzi, R., Ciccone, A., Santilli, I. M., Bersano, A., Sansone, V., Grosso, E., Mandrile, G., Giachino, D. F., Adobbati, L., et al. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.019 · Cited by 15
“A cluster of mutations around exons 3 and 4 was originally reported [13], nevertheless, the mutation spectrum analysis in a significant number of unrelated Italian families with CADASIL suggested that a differentmutational approach is needed from country to country, and perhaps also from region to region in the same c…”
BackgroundVascular Dementia: Potential of Antiplatelet Agents in Prevention
Chabriat, H., & Bousser, M. (2006) · European Neurology · doi:10.1159/000091981 · Cited by 15
“caused by mutation of the Notch3 gene on chromosome 19 [”
BackgroundSelf-citationTang, S., Jeng, J., Lee, M., & Yip, P. (2009) · PubMed · Cited by 15
Konialis, C. P., Hagnefelt, B., Kokkali, G., Pantos, C., & Pángalos, C. (2007) · Prenatal Diagnosis · doi:10.1002/pd.1837 · Cited by 15
“Arterial smooth muscle degeneration, caused by dominant mutations in the NOTCH3 gene in more than 90% of affected individuals, is the pathological basis of this angiopathy (Joutel et al., 1996, 1997; Kalimo et al., 2002, Kalaria et al., 2004).”
BackgroundAlagille syndrome and the notch signaling pathway: New insights into human development
Spinner, N. B. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70032-6 · Cited by 15
CADASIL: new cases and new questions
Rafałowska, J., Fidziańska, A., Dziewulska, D., Podlecka‐Piętowska, A., Szpak, G. M., & Kwieciński, H. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0764-4 · Cited by 15
Investigating the Association Between Notch3 Polymorphism and Migraine
Borroni, B., Brambilla, C., Liberini, P., Rao, R., Archetti, S., Venturelli, E., Gipponi, S., Caimi, L., & Padovani, A. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00344.x · Cited by 15
Young, W. B. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-1-200001040-00026 · Cited by 15
Fornage, M. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0027-5 · Cited by 14
“... genes for some of these rare Mendelian forms of stroke (Table 1). In particular, the genetic basis of the most common form of monogenic stroke, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), was ascribed to mutations in the NOTCH3 gene, which encodes a transme…”
BackgroundResearch Actuality in the Genetics of Stroke
Orlacchio, A., & Bernardi, G. (2006) · Clinical and Experimental Hypertension · doi:10.1080/10641960600549066 · Cited by 14
Catchpoole, D. R., SMALLWOOD, A. V., Joyce, J. A., Murrell, A., LAM, W., TANG, T., Munroe, D. J., Reik, W., Schofield, P. N., & Maher, E. R. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.3.212 · Cited by 14
Two Cases of Japanese CADASIL with Corpus Callosum Lesion.
Iwatsuki, K., Murakami, T., Manabe, Y., Narai, H., Warita, H., Hayashi, T., & Abe, K. (2001) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.195.135 · Cited by 14
Notch Signaling in Vascular Endothelial and Mural Cell Communications
O’Hare, M., & Arboleda‐Velásquez, J. F. (2022) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041159 · Cited by 14
Paraskevas, G. P., Stefanou, M., Constantinides, V. C., Bakola, E., Chondrogianni, M. E., Giannopoulos, S., Kararizou, E. G., Boufidou, F., Zompola, C., Tsantzali, I., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15180 · Cited by 13
“In many European populations, including French, British and German patients, a strong clustering of mutations has been reported in exons 2– 6 and especially in exon 4 [10,41,42].”
BackgroundLee, S. J., Meng, H., Elmadhoun, O., Blaivas, M., & Wang, M. M.-H. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.781 · Cited by 13
“C E R E B R A L A U T O S O M A L dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is caused by mutations in the NOTCH3 gene that create or delete a cysteine residue.(1) Most disease-related changes are point mutations; however, several uncommon mutations of CADASIL have been described…”
BackgroundWeiming, F., Yu-liang, W., Li, Y., Xinsheng, L., Xie, S., & Zhaoxia, L. (2012) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2012.02.026 · Cited by 13
Liu, N., Li, Y., Chen, H., Wei, W., An, Y., & Zhu, G. (2015) · Europe PMC (PubMed Central) · Cited by 13
Neoplastic lesions in CADASIL syndrome: report of an autopsied Japanese case.
Hassan, W. A., Udaka, N., Ueda, A., Ando, Y., & Ito, T. (2015) · Europe PMC (PubMed Central) · Cited by 13
Hung, L. Y., Ling, T. K., Lau, N. K. C., Cheung, W. L., Chong, Y. K., Sheng, B., Kwok, K. M., & Mak, C. M. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.06.050 · Cited by 13
“(Cy s194Ser);(Cys194=), belong to the group of mutations causing alteration in the number of cysteine residues [12,13].”
Joutel, A. (2014) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.135 · Cited by 13
Self-citation
Metadata
- Authors
- Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., Bach, J.-F., & Tournier-Lasserve, E.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Hôpital Lariboisière (FR)
- bioMérieux (France) (FR)
- Genethon (France) (FR)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 350
- Issue
- 9090
- Pages
- 1511-1515
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2153287135
- Cited by
- 682
- References
- 26
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 22 · 2023: 21 · 2022: 27 · 2021: 16 · 2020: 30 · 2019: 20 · 2018: 28 · 2017: 16 · 2016: 12 · 2015: 18 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- CADASIL, Notch3, NOTCH3 mutations, EGF-like repeats, mutation clustering, diagnostic testing, cerebrovascular disease, leukoencephalopathy
- MeSH terms
- Receptor, Notch3, Cerebral Arterial Diseases, Cerebral Infarction, DNA Mutational Analysis, Epidermal Growth Factor, Genetic Testing, Genotype, Humans, Leukoencephalopathy, Progressive Multifocal, Mutation, Proto-Oncogene Proteins, Receptors, Cell Surface, Case-Control Studies, Receptors, Notch
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.